Publications

A full list is also available on Google Scholar. An asterisk (*) indicates equal contribution.

Submitted Manuscripts

  1. Xu Y, Sang P. Efficient estimation for the functional Cox model with interval-censored data.
  2. Xu Y, Zeng D, Lin DY. Robust inference for the Cox proportional hazards model with interval-censored data.
  3. Xu Y, Tian Q, Wang G. Semiparametric regression analysis of right-censored events with perturbed discrete covariates.
  4. Gu Y, Xu Y, Sang P. Varying coefficient model for longitudinal data with informative observation times.
  5. Cheng M, Xu Y, Tian Q, Li P. A goodness-of-fit test for the logistic propensity score model under nonignorable missing data.

Refereed Publications

  1. Xu Y, Zeng D, Lin DY. Checking the Cox proportional hazards model with interval-censored data. Journal of the American Statistical Association, 2025.
    2024 ICSA Student Paper Honorable Mention (earlier version)
  2. Du Y, Paritala S, Xu Y, Maloney P, Lin DY. Durability of 2024–2025 COVID-19 vaccines against JN.1 subvariants. JAMA Internal Medicine, 2025. [News]
  3. Yang X, Shi F, Chen S, Liu Z, Xu Y, Poland GA, Weissman S, Olatosi B, Zhang J, Li X. Effects of COVID-19 vaccination and past SARS-CoV-2 infection on subsequent COVID-19 infection in people with HIV. Journal of Microbiology, Immunology and Infection, 2025.
  4. Lin DY, Du Y, Xu Y, Paritala S, Donahue M, Maloney P. Durability of XBB.1.5 vaccines against Omicron subvariants. New England Journal of Medicine, 2024. [News]
  5. Lin DY*, Xu Y*, Gu Y, Sunny SK, Moore Z, Zeng D. Impact of booster vaccination interval on SARS-CoV-2 infection, hospitalization, and death. International Journal of Infectious Diseases, 2024.
  6. Xu Y, Zeng D, Lin DY. Proportional rates models for multivariate panel count data. Biometrics, 2024.
    2023 ASA Lifetime Data Science Student Paper Award & 2024 ENAR Distinguished Student Paper Award (earlier version)
  7. Lin DY, Du Y, Xu Y, Paritala S, Donahue M, Maloney P. Effectiveness of XBB.1.5 vaccines against Omicron subvariants. Medical Research Archives, 2024.
  8. Xu Y, Zeng D, Lin DY. Marginal proportional hazards models for multivariate interval-censored data. Biometrika, 2023.
  9. Lin DY*, Xu Y*, Gu Y*, Zeng D, Wheeler B, Young H, Sunny SK, Moore Z. Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on Omicron infection and severe outcomes in children under 12 years of age. The Lancet Infectious Diseases, 2023. [News]
  10. Lin DY, Xu Y, Gu Y, Zeng D, Sunny SK, Moore Z. Durability of bivalent boosters against Omicron subvariants. New England Journal of Medicine, 2023. [News]
  11. Lin DY, Xu Y, Gu Y, Zeng D, Wheeler B, Young H, Sunny SK, Moore Z. Effectiveness of bivalent boosters against severe Omicron infection. New England Journal of Medicine, 2023. [News]
  12. Paritala S, Xu Y, Du Y, Donahue M, Maloney P, Lin DY. Effectiveness of bivalent boosters over nine and half months. Journal of Biotechnology and Biomedicine, 2023.
  13. Lin DY, Xu Y, Zeng D, Sunny SK. A cost-benefit analysis of bivalent COVID-19 vaccines. Journal of Biotechnology and Biomedicine, 2023.
  14. Lin DY, Gu Y, Xu Y, Wheeler B, Young H, Sunny SK, Moore Z, Zeng D. Association of primary and booster vaccination and prior infection with SARS-CoV-2 infection and severe COVID-19 outcomes. JAMA, 2022. [News]
  15. Lin DY, Gu Y, Xu Y, Zeng D, Wheeler B, Young H, Sunny SK, Moore Z. Effects of vaccination and previous infection on Omicron infections in children. New England Journal of Medicine, 2022. [News]